| 2-DG | 2-deoxy-D-glucose |
| 5-FU | 5-fluorouracil |
| ApoA-1 | Apolipoprotein A-I |
| BALB | Bagg Albino |
| BCR | Breakpoint cluster region |
| BLNs | Biofunctionalized liposome-like nanovesicles |
| CARs | Chimeric antigen receptors |
| CML | Chronic myeloid leukaemia |
| CpG | 5′-C-phosphate-G-3′ |
| CTLA-4 | Cytotoxic T lymphocyte antigen-4 |
| CXCR4 | C-X-C chemokine receptor type 4 |
| DOX | Doxorubicin |
| DBCO-Sulfo-NHS esters | Dibenzocyclooctyne-sulfo-N-hydroxysuccinimidyl ester |
| EGFR | Epidermal growth factor receptor |
| ESCRT | Endosomal sorting complex required for transport |
| EVs | Extracellular vesicles |
| FASL | Fas ligand, a member of the tumor necrosis factor family |
| GFP | Green fluorescent proteins |
| GITRL | Glucocorticoid-induced tumor necrosis factor receptor family-related ligand |
| HA-PEI/HA-PEG | Hyaluronic acid-poly(ethylene imine)/ hyaluronic acid-poly(ethylene glycol) |
| HDL | High-density lipoprotein |
| HER2 | Human epidermal growth factor receptor 2 |
| hEGF | Human epidermal growth factor |
| ICD | Immunogenic cell death |
| IL-3 | Interleukin-3 |
| imDCs | Immature dendritic cells |
| ISEV | International Society For Extracellular Vesicles |
| KRAS | Ki-Ras2 Kirsten rat sarcoma viral oncogene homolog |
| LAMP | Lysosome-associated membrane protein |
| NK | Natural killer |
| NSCLC | Non-small cell lung cancer |
| NVs | Nanovesicles |
| OVA Ag | Ovalbumin antigen |
| pCD63-OVA | Plasmid DNA encoding ova ag |
| PD-1 | Programmed Cell Death Protein 1 |
| PD1-BCMNs | Program death protein expressed Bioengineered Cell Membrane nanovesicles |
| PDGFR | Platelet-derived growth factor receptor |
| PD-L1 | Programmed death ligand 1 |
| RFP | Red fluorescent proteins |
| SAV-LA | Streptavidin–cadherin |
| SMART-Exo | Synthetic multivalent antibody-retargeted exosome |
| SR-B1 | Scavenger receptor class B type 1 |
| TAM | Tumor-associated macrophages |
| TLR | Toll-like receptor |
| tLyp-1 | Tumor-homing and -penetrating Peptide |
| TME | Tumor micro-environment |
| TNBC | Triple-negative breast cancer |
| TRAIL | TNF-related apoptosis-inducing ligand |
| VSVGs | vesicular stomatitis infection glycoproteins |
| EDC | 1-ethyl-3-(3-dimethylamino propyl)- carbodiimide |
| NHS | N-hydroxysuccinimide |
| cRGDyC | Cyclic arginine-glycine-aspartic acid-tyrosine-cysteine |
| cRGDyK | Cyclic arginine-glycine-aspartic acid-tyrosine-proline |
| VEGF | Vascular endothelial growth factor |
| cL | Cyclo peptide |
| EGFR | Epidermal growth factor receptor |
| PDAC | pancreatic ductal adenocarcinoma |
| EXS/EXO | Exosome |
| OXA | Oxaliplatin |
| aCTLA-4 | Anticytotoxic T-lymphocyte-associated protein-4 antibodies |
| BM-MSC | Bone marrow mesenchymal stem cells |
| PEG | Polyethylene glycol |
| R9 | Polyarginine peptide |
| HepG2 | Hepatoblastoma cell line |
| RGE | Arginine-glycine- glutamic acid |
| Cur | Curcumin |
| SPIONs | Superparamagnetic iron oxide nanoparticles |
| FITC | Fluorescein isothiocyanate |
| SPAAC | Strain-promoted azide–alkyne cycloaddition |
| DBCO | Aza-dibenzocyclooctyne |
| SIRPa | CD47-signal regulatory protein alpha |
| CD47 | Cluster of differentiation 47 |
| EGa1 | Egfr Nanobodies |
| C1C2 | Lactadherin |
| OaAEP1 | Oldenlandia affinis plant ligase |
| CHP | Cholesterol-bearing pullulan |
| LTX | Lipofectamine |
| LI7E | Lipid-sensitive endosmotic |
| RTC | Reticulocyte |
| SPMN | Superparamagnetic nanoparticles |
| Tf | Transferrin |
| LipHA | ligand hyaluronic acid derivative with octadecyl tails |
| CD44 | Cluster of differentiation 44 |
| PDA | Polydopamine |
| AA-PEG | Aminoethyl Anisamide-Polyethylene Glycol |
| DMPE | Diphosphine ligand 1,2-Bis(Dimethyl-Phosphine)Ethane |
| FA | Folic acid |
| DSPE | 1,2-Distearoyl-Sn-Glycero-3-Phosphoethanolamine |
| TNBC | Triple-negative breast cancer |
| BFMV | Biotin- and folate-conjugated microvesicles |
| GALA | Glutamic acid-alanine-leucine-alanine |
| siRNA | Small interfering RNA |
| Muc1 | Mucin 1 |
| HEK293T | Human embryonic kidney 293T |
| Bcl 2 | B-cell lymphoma 2 |